Renaissance Technologies
APGE

Renaissance Technologies’s Apogee Therapeutics APGE Stock Holding History

Renaissance Technologies’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.5M Buy
+146,800
New +$13.2M 0.03% 709
2025
Q3 		– Sell
-41,100
Closed -$1.78M – 3481
2025
Q2 		$1.78M Buy
+41,100
New +$1.56M ﹤0.01% 2181
2024
Q3 		– Sell
-156,204
Closed -$6.15M – 3510
2024
Q2 		$6.15M Buy
156,204
+67,504
+76% +$3.28M 0.01% 1181
2024
Q1 		$5.89M Buy
+88,700
New +$3.87M 0.01% 1309

Other funds holding APGE

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Renaissance Technologies's APGE Position: Q2 2026 in Review

Renaissance Technologies opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 146,800 shares worth $19.5M. The stake represents 0.03% of the portfolio and ranks #709 among its holdings. This is a return to the name: Renaissance Technologies previously reported a position in APGE as recently as Q2 2025.

Renaissance Technologies first reported a position in APGE in Q1 2024 and has held it in 4 quarters since. 289 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Renaissance Technologies held 146,800 shares of Apogee Therapeutics worth $19.5M as of Q2 2026.
  • Apogee Therapeutics was a new Renaissance Technologies position in Q2 2026.
  • Apogee Therapeutics made up 0.03% of Renaissance Technologies's portfolio in Q2 2026, its #709 holding.
  • Renaissance Technologies first reported a position in Apogee Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • 289 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.